| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.69M | 161.69M | 181.09M | 173.70M | 154.82M | 114.09M |
| Gross Profit | 62.30M | 50.35M | 54.74M | 56.94M | 54.23M | 41.34M |
| EBITDA | -135.00K | 4.13M | -29.02M | 16.40M | -34.64M | 8.16M |
| Net Income | -10.55M | -6.62M | -39.98M | 1.82M | -51.00M | -4.54M |
Balance Sheet | ||||||
| Total Assets | 106.82M | 106.82M | 117.10M | 173.45M | 191.82M | 223.59M |
| Cash, Cash Equivalents and Short-Term Investments | 24.08M | 24.08M | 18.23M | 9.88M | 5.77M | 25.10M |
| Total Debt | 11.72M | 11.72M | 15.60M | 25.17M | 24.49M | 29.17M |
| Total Liabilities | 38.19M | 38.19M | 41.91M | 53.22M | 63.72M | 52.51M |
| Stockholders Equity | 66.88M | 66.88M | 73.49M | 118.20M | 126.18M | 169.31M |
Cash Flow | ||||||
| Free Cash Flow | 9.92M | 9.92M | 5.89M | 5.47M | -4.86M | -4.34M |
| Operating Cash Flow | 10.65M | 10.65M | 9.30M | 9.38M | 2.12M | 7.61M |
| Investing Cash Flow | -697.00K | -697.00K | 674.00K | -3.84M | -6.93M | -11.84M |
| Financing Cash Flow | -3.71M | -3.71M | -1.04M | -802.00K | -14.97M | 4.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$7.54B | 21.39 | 6.77% | 2.72% | 29.81% | 10.40% | |
69 Neutral | HK$2.37B | 12.59 | 5.07% | 3.81% | 0.33% | -44.28% | |
68 Neutral | HK$106.40M | 10.56 | 9.25% | 1.89% | 27.91% | 18.87% | |
60 Neutral | HK$626.40M | 12.01 | 8.12% | 8.03% | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$72.83M | -8.50 | -11.91% | ― | -4.50% | 75.98% | |
42 Neutral | HK$816.87M | -5.91 | -465.55% | ― | -17.39% | -45.76% |
Wanjia Group Holdings Ltd. has called an extraordinary general meeting (EGM) for 10 February 2026 in Hong Kong, where shareholders will vote on key capital measures. The board is seeking approval to double the company’s authorised share capital to HK$100 million and to conduct a rights issue of up to 560.2 million new shares at HK$0.08 per share on a one-for-one basis for qualifying shareholders, a move aimed at expanding the company’s capacity to raise equity and potentially strengthening its balance sheet, though it will also dilute existing holdings for those who do not subscribe.
The most recent analyst rating on (HK:0401) stock is a Hold with a HK$0.10 price target. To see the full list of analyst forecasts on Wanjia Group Holdings Ltd. stock, see the HK:0401 Stock Forecast page.
Wanjia Group Holdings Limited plans to double its authorised share capital from HK$50 million to HK$100 million by increasing the number of authorised shares from 1 billion to 2 billion, subject to shareholder approval at an extraordinary general meeting. Conditional on this increase and independent shareholders’ approval, the company will launch a rights issue of one new share for every existing share held at a subscription price of HK$0.08 per rights share, aiming to raise gross proceeds of approximately HK$44.82 million to HK$51.28 million and net proceeds of around HK$40.82 million to HK$47.28 million. The offer will be available only to qualifying shareholders, with compensatory placing arrangements in place, and is intended to strengthen the company’s capital base and provide funding flexibility, which may have implications for existing shareholders through equity dilution balanced against improved liquidity and funding capacity.
The most recent analyst rating on (HK:0401) stock is a Hold with a HK$0.14 price target. To see the full list of analyst forecasts on Wanjia Group Holdings Ltd. stock, see the HK:0401 Stock Forecast page.
Wanjia Group Holdings Ltd. reported a slight increase in revenue for the six months ended September 30, 2025, driven by growth in its Hemodialysis Business. However, the company experienced a loss of HK$0.712 million compared to a profit in the previous year, with no interim dividend declared, indicating financial challenges despite revenue growth.
Wanjia Group Holdings Limited has announced that its Board of Directors will hold a meeting on November 19, 2025, to discuss several key issues. The meeting will focus on approving the unaudited interim results for the six months ending September 30, 2025, considering the payment of an interim dividend, and potentially closing the register of members. This meeting is significant as it will determine the financial direction of the company and could impact shareholder returns and market perception.